{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:12:15Z","timestamp":1761491535873,"version":"build-2065373602"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ogc.2022.10.014","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T22:05:29Z","timestamp":1677017129000},"page":"251-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Antiseizure Medications in Pregnancy"],"prefix":"10.1016","volume":"50","author":[{"given":"Alexandra C.","family":"Moise","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth E.","family":"Gerard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ogc.2022.10.014_bib1","first-page":"142","article-title":"Practice Parameter update: management issues for women with epilepsy\u2014Focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding","volume":"73","author":"Harden","year":"2009","journal-title":"Rep Qual Stand Subcommittee Ther Technol Assess Subcommittee Am Acad Neurol Am Epilepsy Soc"},{"issue":"8","key":"10.1016\/j.ogc.2022.10.014_bib2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/WNL.0000000000003637","article-title":"Predictors of unintended pregnancy in women with epilepsy","volume":"88","author":"Herzog","year":"2017","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ogc.2022.10.014_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1684\/epd.2019.1105","article-title":"Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy","volume":"21","author":"Tomson","year":"2019","journal-title":"Epileptic Disord"},{"doi-asserted-by":"crossref","unstructured":"Hiilesmaa VK, Teramo KA. Fetal and Maternal Risks with Seizures. In Harden C, Thomas SV, Tomson T, editors. Epilepsy in Women. John Wiley & Sons. p. 115\u2013127.","key":"10.1016\/j.ogc.2022.10.014_bib4","DOI":"10.1002\/9781118531037.ch10"},{"issue":"8","key":"10.1016\/j.ogc.2022.10.014_bib5","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archneur.62.8.1304","article-title":"Maternal complex partial seizure associated with fetal distress","volume":"62","author":"Sahoo","year":"2005","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.ogc.2022.10.014_bib6","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1212\/WNL.51.3.904","article-title":"A\u00a0maternal complex partial seizure in labor can affect fetal heart rate","volume":"51","author":"Nei","year":"1998","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ogc.2022.10.014_bib7","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/epi.12621","article-title":"SUDEP and epilepsy-related mortality in pregnancy","volume":"55","author":"Edey","year":"2014","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.ogc.2022.10.014_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1753495X14553257","article-title":"Trends in maternal deaths from epilepsy in the United Kingdom: a 30-year retrospective review","volume":"7","author":"Kapoor","year":"2014","journal-title":"Obstet Med"},{"issue":"8","key":"10.1016\/j.ogc.2022.10.014_bib9","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archneurol.2009.142","article-title":"Affect of seizures during gestation on pregnancy outcomes in women with epilepsy","volume":"66","author":"Chen","year":"2009","journal-title":"Arch Neurol"},{"issue":"26","key":"10.1016\/j.ogc.2022.10.014_bib10","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1056\/NEJMoa2008663","article-title":"Changes in seizure frequency and antiepileptic therapy during pregnancy","volume":"383","author":"Pennell","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ogc.2022.10.014_bib11","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1586\/14737175.2015.1083422","article-title":"Management of epilepsy during pregnancy","volume":"15","author":"Voinescu","year":"2015","journal-title":"Expert Rev Neurother"},{"issue":"8","key":"10.1016\/j.ogc.2022.10.014_bib12","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/epi.12226","article-title":"Exposure to antiepileptic drugs in utero and child development: a prospective population-based study","volume":"54","author":"Veiby","year":"2013","journal-title":"Epilepsia"},{"issue":"3 Epilepsy","key":"10.1016\/j.ogc.2022.10.014_bib13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1212\/01.CON.0000431383.14061.e6","article-title":"Pregnancy, epilepsy, and women's issues","volume":"19","author":"Pennell","year":"2013","journal-title":"Continuum (Minneap Minn)"},{"issue":"9","key":"10.1016\/j.ogc.2022.10.014_bib14","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/jnnp-2013-306318","article-title":"Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers","volume":"85","author":"Campbell","year":"2014","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"3","key":"10.1016\/j.ogc.2022.10.014_bib15","first-page":"579","article-title":"Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy","volume":"261","author":"Veiby","year":"2014","journal-title":"J\u00a0Neurol"},{"issue":"9","key":"10.1016\/j.ogc.2022.10.014_bib16","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1474-4422(12)70103-5","article-title":"Teratogenic effects of antiepileptic drugs","volume":"11","author":"Tomson","year":"2012","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.ogc.2022.10.014_bib17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","article-title":"Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry","volume":"17","author":"Tomson","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ogc.2022.10.014_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.reprotox.2014.02.004","article-title":"The fetal safety of Levetiracetam: a systematic review","volume":"46","author":"Chaudhry","year":"2014","journal-title":"Reprod Toxicol"},{"issue":"13","key":"10.1016\/j.ogc.2022.10.014_bib19","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/bdr2.1526","article-title":"Levetiracetam pregnancy registry: final results and a review of the impact of registry methodology and definitions on the prevalence of major congenital malformations","volume":"111","author":"Scheuerle","year":"2019","journal-title":"Birth Defects Res"},{"issue":"21","key":"10.1016\/j.ogc.2022.10.014_bib20","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Comparative safety of antiepileptic drugs during pregnancy","volume":"78","author":"Hern\u00e1ndez-D\u00edaz","year":"2012","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ogc.2022.10.014_bib21","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/pds.3612","article-title":"Topiramate use in pregnancy and the birth prevalence of oral clefts","volume":"23","author":"Mines","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.ogc.2022.10.014_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0000000000000018","article-title":"Association between topiramate and zonisamide use during pregnancy and low birth weight","volume":"123","author":"Hern\u00e1ndez-D\u00edaz","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ogc.2022.10.014_bib23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ogc.2022.10.014_bib24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.seizure.2021.07.002","article-title":"Zonisamide safety in pregnancy: data from the UK and Ireland epilepsy and pregnancy register","volume":"91","author":"McCluskey","year":"2021","journal-title":"Seizure"},{"issue":"14","key":"10.1016\/j.ogc.2022.10.014_bib25","doi-asserted-by":"crossref","first-page":"e1502","DOI":"10.1212\/WNL.0000000000008687","article-title":"Fetal loss and malformations in the MONEAD study of pregnant women with epilepsy","volume":"94","author":"Meador","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.ogc.2022.10.014_bib26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.seizure.2021.07.030","article-title":"Teratogenic effects of zonisamide","volume":"91","author":"Vajda","year":"2021","journal-title":"Seizure - Eur J Epilepsy"},{"key":"10.1016\/j.ogc.2022.10.014_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.seizure.2021.10.015","article-title":"Malformation risk of new anti-epileptic drugs in women with epilepsy; observational data from the Kerala registry of epilepsy and pregnancy (KREP)","volume":"93","author":"Thomas","year":"2021","journal-title":"Seizure"},{"issue":"9","key":"10.1016\/j.ogc.2022.10.014_bib28","doi-asserted-by":"crossref","first-page":"e790","DOI":"10.1212\/WNL.0000000000005031","article-title":"Teratogenicity of antiepileptic dual therapy: dose-dependent, drug-specific, or both?","volume":"90","author":"Keni","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ogc.2022.10.014_bib29","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.88.16_supplement.P5.231","article-title":"Outcomes following exposure to the antiepileptic drug lacosamide during pregnancy \u2013 results from a global safety database (P5.231)","volume":"88","author":"Golembesky","year":"2017","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ogc.2022.10.014_bib30","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archneurol.2011.133","article-title":"Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations","volume":"68","author":"Holmes","year":"2011","journal-title":"Arch Neurol"},{"issue":"7","key":"10.1016\/j.ogc.2022.10.014_bib31","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/epi.13415","article-title":"Antiepileptic drug combinations not involving valproate and the risk of fetal malformations","volume":"57","author":"Vajda","year":"2016","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.ogc.2022.10.014_bib32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.ogc.2022.10.014_bib33","first-page":"Cd010236","article-title":"Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child","volume":"2014","author":"Bromley","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.ogc.2022.10.014_bib34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp-2012-304270","article-title":"The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs","volume":"84","author":"Bromley","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"16","key":"10.1016\/j.ogc.2022.10.014_bib35","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ogc.2022.10.014_bib36","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamaneurol.2022.1269","article-title":"Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability","volume":"79","author":"Bj\u00f8rk","year":"2022","journal-title":"JAMA Neurol"},{"issue":"11","key":"10.1016\/j.ogc.2022.10.014_bib37","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1111\/epi.16685","article-title":"Enduring language deficits in children of women with epilepsy and the potential role of intrauterine exposure to antiepileptic drugs","volume":"61","author":"Unnikrishnan","year":"2020","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.ogc.2022.10.014_bib38","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/WNL.0000000000001182","article-title":"IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study","volume":"84","author":"Baker","year":"2015","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ogc.2022.10.014_bib39","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/epi.16953","article-title":"Neurodevelopmental outcomes in children exposed to newer antiseizure medications: a systematic review","volume":"62","author":"Knight","year":"2021","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.ogc.2022.10.014_bib40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1212\/WNL.0000000000000030","article-title":"In utero exposure to levetiracetam vs valproate: development and language at 3 years of age","volume":"82","author":"Shallcross","year":"2014","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ogc.2022.10.014_bib41","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jamaneurol.2017.5035","article-title":"Association between prenatal valproate exposure and performance on standardized language and mathematics tests in school-aged children","volume":"75","author":"Elkj\u00e6r","year":"2018","journal-title":"JAMA Neurol"},{"issue":"8760","key":"10.1016\/j.ogc.2022.10.014_bib42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0140-6736(91)90133-A","article-title":"Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group","volume":"338","year":"1991","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ogc.2022.10.014_bib43","first-page":"1926","article-title":"Spontaneous abortion and the prophylactic effect of folic acid supplementation in epileptic women undergoing antiepileptic therapy","volume":"255","author":"Pittschieler","year":"2008","journal-title":"J\u00a0Neurol"},{"issue":"6","key":"10.1016\/j.ogc.2022.10.014_bib44","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/jama.2012.155925","article-title":"Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children","volume":"309","author":"Sur\u00e9n","year":"2013","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.ogc.2022.10.014_bib45","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.2011.1433","article-title":"Folic acid supplements in pregnancy and severe language delay in children","volume":"306","author":"Roth","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ogc.2022.10.014_bib46","doi-asserted-by":"crossref","first-page":"e605","DOI":"10.1212\/WNL.0000000000200669","article-title":"Folic acid and risk of preterm birth, preeclampsia and fetal growth restriction among women with epilepsy: a prospective cohort study","volume":"99","author":"Alvestad","year":"2022","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ogc.2022.10.014_bib47","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jamaneurol.2022.2977","article-title":"Cancer risk in children of mothers with epilepsy and high-dose folic acid use during pregnancy","volume":"79","author":"Vegrim","year":"2022","journal-title":"JAMA Neurology"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.014_bib48","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1756285615623934","article-title":"Management of epilepsy during pregnancy: an update","volume":"9","author":"Patel","year":"2016","journal-title":"Ther Adv Neurol Disord"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.014_bib49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/acn3.29","article-title":"Model-Based Lamotrigine Clearance Changes During Pregnancy: Clinical Implication","volume":"1","author":"Polepally","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"10.1016\/j.ogc.2022.10.014_bib50","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jamaneurol.2021.5487","article-title":"Antiseizure medication concentrations during pregnancy: results from the maternal outcomes and neurodevelopmental effects of antiepileptic drugs (MONEAD) study","volume":"79","author":"Pennell","year":"2022","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.ogc.2022.10.014_bib51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/epi.12109","article-title":"Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications","volume":"54","author":"Tomson","year":"2013","journal-title":"Epilepsia"},{"issue":"3a","key":"10.1016\/j.ogc.2022.10.014_bib52","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/BF01962699","article-title":"Pharmacokinetics of valproate in pregnancy: mother-foetus-newborn","volume":"14","author":"Johannessen","year":"1992","journal-title":"Pharm Weekbl Sci"},{"issue":"22 Pt 2","key":"10.1016\/j.ogc.2022.10.014_bib53","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1212\/01.wnl.0000289511.20864.2a","article-title":"Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency","volume":"70","author":"Pennell","year":"2008","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ogc.2022.10.014_bib54","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1324","article-title":"Duration of breastfeeding and risk of SIDS: an individual participant data meta-analysis","volume":"140","author":"Thompson","year":"2017","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ogc.2022.10.014_bib55","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1740-8709.2008.00176.x","article-title":"Breastfeeding protects against infectious diseases during infancy in industrialized countries. A systematic review","volume":"5","author":"Duijts","year":"2009","journal-title":"Matern Child Nutr"},{"issue":"4","key":"10.1016\/j.ogc.2022.10.014_bib56","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jamaneurol.2019.4443","article-title":"Antiepileptic drug exposure in infants of breastfeeding mothers with epilepsy","volume":"77","author":"Birnbaum","year":"2020","journal-title":"JAMA Neurol"},{"issue":"22","key":"10.1016\/j.ogc.2022.10.014_bib57","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1212\/WNL.0b013e3181ffe4a9","article-title":"Effects of breastfeeding in children of women taking antiepileptic drugs","volume":"75","author":"Meador","year":"2010","journal-title":"Neurology"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985452200105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985452200105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:25:49Z","timestamp":1760178349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985452200105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S088985452200105X"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2022.10.014","relation":{},"ISSN":["0889-8545"],"issn-type":[{"type":"print","value":"0889-8545"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiseizure Medications in Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2022.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}